FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to medicine, in particular to a pharmaceutical composition, which contains lorazepam beads with sustained release and with prolonged delayed release.
EFFECT: implementation of the invention allows to create a composition for the delivery of lorazepam in a prolonged fashion and provide once daily dosing, which maintains 24-hour therapeutic effect under steady state conditions.
22 cl, 3 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF ESSENTIAL TREMOR, USING (R)-2-(4-ISOPROPYLPHENYL)-N-(1-(5-(2,2,2-TRIFLUORETHOXY)PYRIDINE-2-YL)ETHYL)ACETAMIDE | 2019 |
|
RU2780318C1 |
| TACROLIMUS FOR IMPROVED TREATMENT OF PATIENTS WITH GRAFTS | 2009 |
|
RU2574006C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HELICOBACTER PYLORI | 2014 |
|
RU2671400C2 |
| MODIFIED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING FEBUXOSTAT | 2011 |
|
RU2602188C2 |
| SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION CONTAINING RIVASTIGMINE | 2016 |
|
RU2727721C2 |
| ANTIEMETIC EXTENDED RELEASE SOLID DOSAGE FORMS | 2014 |
|
RU2679448C2 |
| PHARMACEUTICAL COMPOSITIONS OF ACOTIAMIDE AND PROTON PUMP INHIBITOR | 2019 |
|
RU2820820C2 |
| SOLID COMPOSITIONS BASED ON BETAHISTINE FOR ORAL ADMINISTRATION WITH NON-PULSATING PROLONGED RELEASE | 2018 |
|
RU2774644C2 |
| ORAL DOSAGE FORMS OF TOFACITINIB WITH CONTINUOUS RELEASE | 2014 |
|
RU2790166C2 |
| PHARMACEUTICAL COMPOSITIONS WITH DEFERRED RELEASE CONTAINING VALPROIC ACID AND THEIR USE | 2017 |
|
RU2760304C2 |
